AU1170301A - Inhibition of amyloidoses by using aromatic or heteroaromatic compounds substituted by electron-withdrawing groups - Google Patents

Inhibition of amyloidoses by using aromatic or heteroaromatic compounds substituted by electron-withdrawing groups

Info

Publication number
AU1170301A
AU1170301A AU11703/01A AU1170301A AU1170301A AU 1170301 A AU1170301 A AU 1170301A AU 11703/01 A AU11703/01 A AU 11703/01A AU 1170301 A AU1170301 A AU 1170301A AU 1170301 A AU1170301 A AU 1170301A
Authority
AU
Australia
Prior art keywords
amyloidoses
inhibition
electron
aromatic
withdrawing groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11703/01A
Other languages
English (en)
Inventor
Paulo Roberto Ferreira Louzada Jr.
Sergio Teixeira Ferreira
Fernanda Guarino De Felice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade Federal do Rio de Janeiro UFRJ
Original Assignee
Universidade Federal do Rio de Janeiro UFRJ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade Federal do Rio de Janeiro UFRJ filed Critical Universidade Federal do Rio de Janeiro UFRJ
Publication of AU1170301A publication Critical patent/AU1170301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/06—Phenols the aromatic ring being substituted by nitro groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU11703/01A 1999-10-18 2000-10-18 Inhibition of amyloidoses by using aromatic or heteroaromatic compounds substituted by electron-withdrawing groups Abandoned AU1170301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BR9904931-7A BR9904931A (pt) 1999-10-18 1999-10-18 Inibição de amiloidoses
BR9904931 1999-10-18
PCT/IB2000/001687 WO2001028546A1 (en) 1999-10-18 2000-10-18 Inhibition of amyloidoses by using aromatic or heteroaromatic compounds substituted by electron-withdrawing groups

Publications (1)

Publication Number Publication Date
AU1170301A true AU1170301A (en) 2001-04-30

Family

ID=4073716

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11703/01A Abandoned AU1170301A (en) 1999-10-18 2000-10-18 Inhibition of amyloidoses by using aromatic or heteroaromatic compounds substituted by electron-withdrawing groups

Country Status (3)

Country Link
AU (1) AU1170301A (pt)
BR (1) BR9904931A (pt)
WO (1) WO2001028546A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317048B1 (it) * 2000-06-23 2003-05-26 Sigma Tau Ind Farmaceuti Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie
WO2007045593A2 (en) * 2005-10-18 2007-04-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Naphthyl derivatives as inhibitors of beta-amyloid aggregation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
IT1282736B1 (it) * 1996-05-21 1998-03-31 Angelini Ricerche Spa Uso di derivati del p-amminofenolo per preparare composizioni farmaceutiche utili nel trattamento di malattie neurodegenerative
MA26553A1 (fr) * 1997-10-17 2004-12-20 Centaur Pharmaceuticals Inc Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la

Also Published As

Publication number Publication date
BR9904931A (pt) 2001-06-12
WO2001028546A1 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
AU1367599A (en) Aromatic heterocyclic compounds as anti-inflammatory agents
AU2002224064A1 (en) Substituted benzene derivatives or salts thereof
NO20013559D0 (no) Aromatiske heterocykliske forbindelser som anti- inflammatoriske midler
AU5108000A (en) Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
WO1999002514A3 (en) Epothilone derivatives
AU2722797A (en) Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
HUP0204034A3 (en) Stable salts of novel derivatives of 3,3-diphenylpropylamines
AU5043500A (en) Antibacterial compounds
AU5559100A (en) Paint stripper compositions
AU2002246411A1 (en) Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
DE60007665D1 (de) Lösemittelfreie filmbildende klarlackzusammensetzung
AUPP818099A0 (en) New n-containing heterocyclic compounds
AU2010601A (en) Organic compounds
AU7404700A (en) Novel aromatic compounds
AU4395399A (en) Five-membered heteroaryl compounds
AU2623399A (en) 3-hydroxy-4-aryl-5-pyrazoline derivatives as herbicides
AU1597201A (en) Pyrrolecarbonylimino derivatives as naaladase inhibitors
AU5852300A (en) Heteroaromatic ring compounds
AU2567300A (en) Inhibition of angiogenesis with epigallocatechin-3-gallate
AU4041099A (en) Use of spinosynes as soil insecticides
AU2001240723A1 (en) The use of gdnf family-related compounds for manufacturing products for treatingtesticular tumors
AU3997700A (en) Anti-first-pass effect compounds
PT1206462E (pt) Compostos heterociclicos para inibicao da angiogenese
AU1170301A (en) Inhibition of amyloidoses by using aromatic or heteroaromatic compounds substituted by electron-withdrawing groups
AU6824700A (en) Organic compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 32, PAGE(S) 6822-6826 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 10246/01, 10247/01, 10298/01, 10303/01, 10314/01, 10367/01, 10473/01, 10477/01, 11343/01, 11349/01, 11386/01, 11389/01, 11698/01, 11703/01, 11747/01, 11791/01, 12723/01, 12735/01, 13106/01, 13110/01, 13111/01, 13112/01, 13113/01, 13114/01, 13115/01 AND 16967/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase